<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146617">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01191814</url>
  </required_header>
  <id_info>
    <org_study_id>F100513025</org_study_id>
    <nct_id>NCT01191814</nct_id>
  </id_info>
  <brief_title>Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression</brief_title>
  <official_title>Multicenter Randomized Trial COmparing Covered Metal and Plastic Stents for Preoperative Biliary Decompression in Pancreatic Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Florida Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Florida Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Covered self expandable metal stents (CSEMS) are three times larger in diameter than 10 Fr
      plastic stents. When compared to plastic stents, randomized trials have shown longer patency
      and fewer stent-related complications for CSEMS. The investigators hypothesize that
      placement of CSEMS would be a better treatment option for preoperative biliary decompression
      in patients with pancreatic cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Covered self expandable metal stents (CSEMS) are three times larger in diameter than 10 Fr
      plastic stents. When compared to plastic stents, randomized trials have shown longer patency
      and fewer stent-related complications for CSEMS. The investigators hypothesize that
      placement of CSEMS would be a better treatment option for preoperative biliary decompression
      in patients with pancreatic cancer as there will be better drainage of the obstructed
      biliary system with fewer adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complications related to stent dysfunction</measure>
    <time_frame>30 days</time_frame>
    <description>Complications related to stent dysfunction which include hyperbilirubinemia or cholangitis that warrant stent exchange (repeat intervention by ERCP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural complications</measure>
    <time_frame>30 days</time_frame>
    <description>Complications related to the procedure which includes pancreatitis, perforation or hemorrhage.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Obstructive Jaundice</condition>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>Metal stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with pancreatic cancer causing bile duct obstruction will be treated by placement of a metal stent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plastic Stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with pancreatic cancer causing bile duct obstruction will be treated by placement of a plastic stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Metal stent</intervention_name>
    <description>Patients with pancreatic cancer causing bile duct obstruction will be treated by placement of a metal stent.</description>
    <arm_group_label>Metal stent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Plastic stent</intervention_name>
    <description>Patients with pancreatic cancer causing bile duct obstruction will be treated by placement of a 10Fr plastic stent.</description>
    <arm_group_label>Plastic Stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with pancreatic cancer and mass in the head of pancreas causing jaundice.

          -  Patients 19 yrs of age and older

          -  Serum bilirubin &gt; 2mg/dl

          -  CT: No evidence of distant metastasis or local vascular invasion (tumor surrounding
             portal or mesenteric vessels for more than 180 degrees of their circumference or an
             irregular vessel margin).

        Exclusion Criteria:

          -  Karnofsky score &lt; 60

          -  Prior (ERCP or PTC) attempts at biliary decompression for the same indication

          -  Tumor-related gastric outlet obstruction (vomiting and oral intake of &lt; 1L/day)

          -  Ongoing or planned neoadjuvant therapy

          -  Cholangitis at presentation or coagulopathy needing reversal medication

          -  Post-surgical anatomy

          -  Multiple extra-hepatic biliary strictures or concomitant stricture in liver hilum

          -  Failed ERCP's (Definition: Inability to deploy a biliary stent thereby requiring a
             PTC or surgery).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shyam Varadarajulu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shyam Varadarajulu, MD</last_name>
    <phone>2059347989</phone>
    <email>svaradarajulu@uab.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shyam Varadarajulu, MD</last_name>
      <phone>205-934-7989</phone>
    </contact>
    <investigator>
      <last_name>Shyam Varadarajulu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32814</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shyam Varadarajulu, MD</last_name>
      <phone>407-303-2570</phone>
    </contact>
    <contact_backup>
      <last_name>Amy Logue, RN</last_name>
      <email>amy.logue@flhosp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Shyam Varadarajulu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eric Goldberg</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Goldberg, MD</last_name>
      <email>egoldber@medicine.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Eric Goldberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Yachimski, MD</last_name>
      <phone>615-322-0128</phone>
      <email>patrick.yachimski@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Patrick Yachimski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <lastchanged_date>April 15, 2015</lastchanged_date>
  <firstreceived_date>August 12, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Florida Hospital</investigator_affiliation>
    <investigator_full_name>Shyam Varadarajulu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>pancreatic cancer</keyword>
  <keyword>obstructive jaundice</keyword>
  <keyword>Obstructive jaundice secondary to pancreatic cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Jaundice, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
